Logindo Samudramakmur Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? Logindo Samudramakmur Tbk. trades at Rp108 (market cap 655.36B, 14M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp72 (market cap 109.38B, 56.29M 24h volume). The key difference: Logindo Samudramakmur Tbk. is far larger — about 6× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (56.29M versus 14M). Which is the better fit depends on your goals.
| LEAD | MEDS | |
|---|---|---|
Market Cap | 655.36B | 109.38B |
Volume | 14M | 56.29M |
Lot | 140K | 562.86K |
Turnover | 1.53B | 4.16B |
Average Price | 109.53 | 73.89 |
Value | 1.53B | 4.16B |
Indicative Equilibrium Price | 114 | 71 |
Indicative Equilibrium Volume | 600 | 205 |
Trailing returns across standard periods
Latest headlines on both assets
PT Logindo Samudramakmur Tbk (the Company) is domiciled and was established in Jakarta, Indonesia based on Notarial Deed No. 55 of Nurul Hidajati Handoko, SH., Public Notary in Jakarta dated August 23, 1995. The company currently owns and operates a fleet of 58 offshore support with various types and functions. The company has a portfolio of customers ranging from mining oil and gas local to multinational.
Read more on LEAD →PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →